Free US shipping for orders above $200 • Save 20% on 10-vial bundles

TB-500 10mg

TB-500

Starting at $72.00

Independently tested by Novagen Analytical Labs

Batch TB5086831 · HPLC tested 26 June 2026

Verify this batch with the lab View the certificate

Every batch we sell carries its own verification key. This one is NGL-2026-Q5ZG2N. Enter it on the laboratory's own website and it returns the certificate for this exact batch. That page belongs to the lab, not to us.

TB-500 (Thymosin Beta-4) is a synthetic research peptide modeled after a naturally occurring protein present in most mammalian cells. It has been widely studied for its role in tissue regeneration, wound healing, and inflammation response.
In research settings, TB-500 has been observed to promote cell migration, angiogenesis (formation of new blood vessels), and tissue remodeling, processes that are essential in cellular repair studies. These findings have made it an important focus in regenerative and recovery-based peptide research.

Choose your strength
Choose your quantity

This order qualifies for free US shipping.

In Stock

This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.

Ships from the USADispatched from our United States warehouse
3 to 5 business daysStandard delivery, US wide
International shippingFree on orders over $350
TrackedTracking sent when it leaves the warehouse
Bacteriostatic waterOne 3 ml vial per peptide vial, $13.00 each. Required to reconstitute.
Add
Often researched together
Title Range Discount
Volume pricing - 5% at 5+, 20% at 10+ 5 - 9 5%
Volume pricing - 5% at 5+, 20% at 10+ 10 + 20%

Data Sheet

Molecular Formula C₂₁₂H₃₅₀N₅₆O₇₈S
CAS Number 77591‑33‑4
Molar Mass 4,963.44 g/mol
Amino Acid Sequence Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
PubChem CID 16132341
Primary Research Area Healing & Recovery
Tissue Repair & Remodeling
Anti-inflammatory Effects
Angiogenesis (New Blood Vessel Formation)
Cell Migration
Stem Cell Differentiation
Muscle Tissue Repair
Heart Muscle Regeneration
Soft Tissue Regeneration (Joint Pain, Tendons, Ligaments, Cartilage)
Anti-aging Properties
Purity ≥98%
Research Summary Description
Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 to remind the adult organs of their embryonic state—new directions in anti-aging regenerative therapies Summary: Studies involving laboratory rats showed that administration of Tβ4 (from which TB500 is derived) led to faster healing, thicker and longer collagen fiber bundles, and less scarring in wounds.

Citation: Maar, K., Maar, M., & Maar, T. (2024). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies. Cells, 13(1), 85.
Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair. Summary: TB500, like its parent Tβ4, possesses anti-inflammatory capabilities. It helps reduce swelling, redness, and pain associated with injuries by controlling the inflammatory response.

Citation: Siam Clinic Thailand. (n.d.). Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair.
Local and systemic peptide therapies for soft tissue regeneration: a narrative review Summary: This review identified various peptides, including those related to TB500, demonstrating efficacy in soft tissue repair. It noted that oral and intra-articular peptides showed distinct advantages in soft tissue regeneration, with intra-articular routes providing localized effects and oral routes offering systemic benefits.

Citation: Canapp Jr, S. O., Leasure, C. S., & Canapp, D. A. (2024). Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Cells, 13(18), 1545.
Thymosin beta 4 and cardiac repair Summary: This study explores the role of Thymosin Beta-4 (Tβ4) in cardiac repair, particularly after myocardial infarction (heart attack). It highlights Tβ4's ability to inhibit myocardial cell death, stimulate new blood vessel growth (angiogenesis), and activate endogenous cardiac progenitor cells, effectively ""reminding"" the adult heart of its embryonic program. The study suggests that Tβ4 can initiate simultaneous myocardial and vascular regeneration after systemic administration in vivo.

Citation:
Shrivastava, S., Srivastava, D., Olson, E. N., DiMaio, J. M., & Bock-Marquette, I. (2010). Thymosin beta 4 and cardiac repair. Annals of the New York Academy of Sciences, 1194(1), 87–96. https://doi.org/10.1111/j.1749-6632.2010.05468.x
Neuroprotective and neurorestorative effects of Thymosin beta 4 treatment following experimental traumatic brain injury Summary: This preclinical study investigated the therapeutic potential of Thymosin Beta-4 (Tβ4) in a rat model of traumatic brain injury (TBI). The findings indicated that Tβ4 treatment significantly improved neurological severity scores and reduced the incidence of motor deficits in TBI rats. Histological data showed that early Tβ4 treatment reduced cortical lesion volume and hippocampal cell loss. These results suggest that Tβ4 provides neuroprotection and neurorestoration, even when administered hours after the injury.

Citation:
Wang, Y., Lu, Y., & Li, J. (2012). Neuroprotective and neurorestorative effects of Thymosin beta 4 treatment following experimental traumatic brain injury. Neural Regeneration Research, 7(34), 2686–2693. https://doi.org/10.3969/j.issn.1673-5374.2012.34.004

Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 to remind the adult organs of their embryonic state—new directions in anti-aging regenerative therapies

Summary: Studies involving laboratory rats showed that administration of Tβ4 (from which TB500 is derived) led to faster healing, thicker and longer collagen fiber bundles, and less scarring in wounds.

Citation: Maar, K., Maar, M., & Maar, T. (2024). Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies. Cells, 13(1), 85.

Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair.

Summary: TB500, like its parent Tβ4, possesses anti-inflammatory capabilities. It helps reduce swelling, redness, and pain associated with injuries by controlling the inflammatory response.

Citation: Siam Clinic Thailand. (n.d.). Thymosin Beta-4 (TB-500) is a peptide that has gained attention in recent years for its potential to promote healing and tissue repair.

Local and systemic peptide therapies for soft tissue regeneration: a narrative review

Summary: This review identified various peptides, including those related to TB500, demonstrating efficacy in soft tissue repair. It noted that oral and intra-articular peptides showed distinct advantages in soft tissue regeneration, with intra-articular routes providing localized effects and oral routes offering systemic benefits.

Citation: Canapp Jr, S. O., Leasure, C. S., & Canapp, D. A. (2024). Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Cells, 13(18), 1545.

Thymosin beta 4 and cardiac repair

Summary: This study explores the role of Thymosin Beta-4 (Tβ4) in cardiac repair, particularly after myocardial infarction (heart attack). It highlights Tβ4's ability to inhibit myocardial cell death, stimulate new blood vessel growth (angiogenesis), and activate endogenous cardiac progenitor cells, effectively ""reminding"" the adult heart of its embryonic program. The study suggests that Tβ4 can initiate simultaneous myocardial and vascular regeneration after systemic administration in vivo.

Citation:
Shrivastava, S., Srivastava, D., Olson, E. N., DiMaio, J. M., & Bock-Marquette, I. (2010). Thymosin beta 4 and cardiac repair. Annals of the New York Academy of Sciences, 1194(1), 87–96. https://doi.org/10.1111/j.1749-6632.2010.05468.x

Neuroprotective and neurorestorative effects of Thymosin beta 4 treatment following experimental traumatic brain injury

Summary: This preclinical study investigated the therapeutic potential of Thymosin Beta-4 (Tβ4) in a rat model of traumatic brain injury (TBI). The findings indicated that Tβ4 treatment significantly improved neurological severity scores and reduced the incidence of motor deficits in TBI rats. Histological data showed that early Tβ4 treatment reduced cortical lesion volume and hippocampal cell loss. These results suggest that Tβ4 provides neuroprotection and neurorestoration, even when administered hours after the injury.

Citation:
Wang, Y., Lu, Y., & Li, J. (2012). Neuroprotective and neurorestorative effects of Thymosin beta 4 treatment following experimental traumatic brain injury. Neural Regeneration Research, 7(34), 2686–2693. https://doi.org/10.3969/j.issn.1673-5374.2012.34.004

All content and product details on this website are provided solely for informational and educational purposes.

View Cart (0 items)

Your cart is empty

Start Shopping